BWX Technologies Equity Method Investments increased by 5.0% to $157.63M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 27.1%, from $124.02M to $157.63M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 15.9% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $78.14M | $84.64M | $85.28M | $101.86M | $113.40M | $107.43M | $100.20M | $106.05M | $104.31M | $105.05M | $88.61M | $91.01M | $91.91M | $98.39M | $99.40M | $124.02M | $175.64M | $175.74M | $150.14M | $157.63M |
| QoQ Change | — | +8.3% | +0.8% | +19.4% | +11.3% | -5.3% | -6.7% | +5.8% | -1.6% | +0.7% | -15.7% | +2.7% | +1.0% | +7.0% | +1.0% | +24.8% | +41.6% | +0.1% | -14.6% | +5.0% |
| YoY Change | — | — | — | — | +45.1% | +26.9% | +17.5% | +4.1% | -8.0% | -2.2% | -11.6% | -14.2% | -11.9% | -6.3% | +12.2% | +36.3% | +91.1% | +78.6% | +51.0% | +27.1% |
| Segment | Q4 '21 | Q4 '22 | Q4 '23 |
|---|---|---|---|
| Government Operations | $85.28M | $100.20M | $88.61M |
| Commercial Operations | $0.00 | $0.00 | $0.00 |
| Total | $85.28M | $100.20M | $88.61M |
Commercial Operations, Government Operations were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.